Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 21, 2018
Pharmacy Choice - News - Front Page Healthcare News - May 21, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/21/18 - "Covalent Conjugates of Bet Inhibitors and Alpha Amino Acid Esters" in Patent Application Approval Process (USPTO 20180117165)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors BROWN, John Alexander; JONES, Katherine Louise; PRINJHA, Rabinder Kumar; WITHERINGTON, Jason, filed on March 17, 2016, was made available online on May 10, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents
5/21/18 - "Method of Preparing Glucagon-Like Peptide-2 (Glp-2) Analog" in Patent Application Approval Process (USPTO 20180118800)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors CHEN, Shih-Lin; HSIUNG, Ting-Yu, filed on January 17, 2017, was made available online on May 10, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a compan
5/21/18 - "Pharmaceutical Composition for Oral Administration" in Patent Application Approval Process (USPTO 20180116965)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors SUDA, Yumiko; SAKAI, Toshiro; KOJIMA, Ryo; OYAMA, Dal; NISHIMURA, Koji; NAIKI, Kumi, filed on April 27, 2016, was made available online on May 10, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This pa
5/21/18 - "Radiolabeled Active Targeting Pharmaceutical Composition and the Use Thereof" in Patent Application Approval Process (USPTO 20180117188)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors WANG, Hsin-Ell; HSIA, Chien-Chung; WENG, Mao-Chi; LIN, Kun-Liang; KAO, Hao-Wen; CHEN, Chao-Cheng; CHI, Kwan-Hwa; TIEN, Der-Chi; LIN, Wuu-Jyh, filed on September 14, 2017, was made available online on May 10, 2018, according to news reporting origina
5/21/18 - Akershus University Hospital Reports Findings in Multiple Sclerosis [Adherence to subcutaneous interferon beta-1a treatment using an electronic...
By a News Reporter-Staff News Editor at Clinical Trials Week Researchers detail new data in Autoimmune Diseases and Conditions- Multiple Sclerosis. According to news reporting out of Loerenskog, Norway, by NewsRx editors, research stated, "Disease modifying drugs help control the course of relapsing remitting multiple sclerosis; however, good adh
5/21/18 - Allowance cut bitter pill for lab technicians, pharmacists [NewsDay (Zimbabwe)]
But in a statement yesterday, the Zimbabwe Association of Medical Laboratory and Clinical Scientists accused the HSB of breaching the parties collective bargaining agreement, which stipulated that $720 was the minimum fee that the health workers were to get as on-call duties. The CBA 2 of 2018 states that the new on call allowances sliding rates
5/21/18 - Amneal Initiates Phase 3 Study for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa CD-LD in Advanced Parkinson's...
By a News Reporter-Staff News Editor at Pharma Business Week Amneal, a specialty pharmaceutical company, announced it has initiated a Phase 3 trial for IPX203. The IPX203 Phase 3 protocol has been agreed upon with the Food and Drug Administration in a Special Protocol Assessment. Keywords for this news article include: Antiparkinson Agents, Amnea
5/21/18 - AstraZeneca PLC Announces Lokelma approved in the US for the treatment of adults with hyperkalaemia
Sean Bohen, Executive Vice President, Global Medicines Development and Chief Medical Officer at AstraZeneca, said: "We are pleased by today's FDA approval of Lokelma as it enables us to help address a long-standing clinical need with a new medicine that offers rapid and sustained treatment for adults with hyperkalaemia. Steven Fishbane, MD, Profess
5/21/18 - AstraZeneca Reports Regulatory Submission In Japan For Forxiga
LONDON- AstraZeneca PLC announced the company has. submitted a supplemental new drug application to Japan's Pharmaceuticals and Medical Devices Agency for the use of Forxiga, a selective sodium-glucose co-transporter 2 inhibitor, as an oral adjunct treatment to insulin in adults with type-1 diabetes. Forxiga is also under regulatory review in Europ
5/21/18 - AstraZeneca: FDA Approves Lokelma To Treat Adults With Hyperkalaemia
LONDON- British drug major AstraZeneca announced Monday that the US Food and Drug Administration or FDA has approved Lokelma, formerly ZS-9, for the treatment of adults with hyperkalaemia. The European Commission granted marketing authorisation for Lokelma in the European Union on March 22, 2018. Sean Bohen, Chief Medical Officer at AstraZeneca, sa
5/21/18 - BioClin Therapeutics, Inc., Completes $50 Million Series B Financing with Addition of New Investors
By a News Reporter-Staff News Editor at Clinical Trials Week BioClin Therapeutics, Inc., a clinical stage drug development company developing a first-in-class anti-FGFR3 monoclonal antibody for metastatic bladder cancer, announced expansion of its Series B financing to $50 million to broaden its clinical development activities.
5/21/18 - Biohaven Initiates Expanded Access Program for Sublingual BHV-0223 ZYDIS Orally Dissolving Tablets for Patients with Amyotrophic Lateral Sclerosis...
By a News Reporter-Staff News Editor at Pharma Business Week Biohaven Pharmaceutical Holding Company Ltd. announced that it has established an expanded access program with sublingual BHV-0223, an investigational drug candidate, for patients with amyotrophic lateral sclerosis. Biohaven anticipates submitting a New Drug Application for BHV-0223 to.
5/21/18 - Biolex Sells LEX System to Synthon and Initiates Sale of Locteron
By a News Reporter-Staff News Editor at Clinical Trials Week Biolex Therapeutics, Inc. announced that it has sold its LEX System, a proprietary platform for the development and production of biologics, to Synthon, a Netherlands- based specialty pharmaceutical company. Also included in the sale were two preclinical product candidates uniquely enab
5/21/18 - Cantargia Receives Notice of Allowance From Uspto for the Antibody Can03
Cantargia AB today announces that the United States Patent and Trademark Office has issued a Notice of Allowance for the company's patent application 15/ 501,710 directed to the antibody CAN03, which is of relevance for Cantargia's CANxx project.. Cantargia develops antibody based pharmaceuticals against the interleukin 1 receptor accessory prote
5/21/18 - Capso-Vision medical procedure introduced at CHK
Civil Hospital Karachi has introduced Capso-Vision medical device innovator specializing in diagnostic imaging of the gastrointestinal system. Additional Medical Superintendent, CHK, Dr Arif Niaz, said Capso-Vision medical device had been introduced with aim to to empower physicians and patients, which provide superior clinical outcomes and improve
5/21/18 - Cardiovascular safety concerns over smoking-cessation drug misleading
By a News Reporter-Staff News Editor at Clinical Trials Week A popular smoking cessation medication has been under a cloud of suspicion ever since the Canadian Medical Association Journal published a study in July 2011 reporting "risk of serious adverse cardiovascular events associated with varenicline." "We found no clinically or statistically.
5/21/18 - Carnegie Mellon and McGill researchers challenge post-marketing trial practices
By a News Reporter-Staff News Editor at Clinical Trials Week PITTSBURGH- Current research ethics focuses on protecting study participants, but according to bioethicists from Carnegie Mellon University and McGill University, these efforts fail to prevent problems that undermine the social value of research. Published in Science, CMU's Alex John Lo
5/21/18 - Celsion Announces ThermoDox Commercial Supply Agreement With Hisun
By a News Reporter-Staff News Editor at Pharma Business Week Celsion Corporation, a leading oncology drug development company, announced that it has signed a long term commercial supply agreement with Zhejiang Hisun Pharmaceutical Co. Ltd., a leading pharmaceutical company in China, for the production of ThermoDox , Celsion's proprietary...
5/21/18 - Chugai's Anti-IL-31 Receptor A Humanized Monoclonal Antibody "nemolizumab," Long Term Data from Global Phase II Study Published in Journal of Allergy...
Chugai's Anti-IL-31 Receptor A Humanized Monoclonal Antibody "nemolizumab," Long Term Data from Global Phase II Study Published in Journal of Allergy and Clinical Immunology Online. By a News Reporter-Staff News Editor at Pharma Business Week Chugai Pharmaceutical Co., Ltd. announced that the long-term data from a global phase II study for nemoli
5/21/18 - Clean out the medicine cabinet
Spring cleaning takes on an entirely new meaning when getting ride of expired or unsafe medicines. The U.S. Food and Drug Administration says the medicine expiration date is critical when determining if a product is safe to use and will work as intended. Furthermore, keeping too many medications in a home particularly pain prescriptions can l
5/21/18 - Click Therapeutics Awarded National Institutes of Health NIH Grant for Clickotine Digital Therapeutic Study
By a News Reporter-Staff News Editor at Clinical Trials Week Click Therapeutics, Inc., has been awarded a National Institutes of Health Small Business Innovation and Research grant through the National Institute of Drug Abuse. Clickotine will be compared head to head with the National Cancer Institute's smoking cessation app QuitGuide.
5/21/18 - Cytomegalovirus in Transplantation: Developing Drugs To Treat or Prevent Disease; Draft Guidance for Industry; Availability
SUMMARY: The Food and Drug Administration is announcing the availability of a draft guidance for industry entitled "Cytomegalovirus in Transplantation: Developing Drugs to Treat or Prevent Disease." DATES: Submit either electronic or written comments on the draft guidance by July 20, 2018 to ensure that the Agency considers your comment on this dra
5/21/18 - Daiichi Sankyo Announces Single Agent Quizartinib Significantly Prolongs Overall Survival Compared with Chemotherapy in Patients with...
By a News Reporter-Staff News Editor at Clinical Trials Week Daiichi Sankyo Company, Limited announces that the pivotal QuANTUM-R phase 3 study of single agent quizartinib met its primary endpoint of significantly prolonging overall survival compared to salvage chemotherapy in patients with relapsed/refractory acute myeloid leukemia with FLT3-ITD
5/21/18 - Data from Aalborg University Hospital Provide New Insights into Chronic Pancreatitis (A pilot-study of hypnotherapy as complementary treatment for...
By a News Reporter-Staff News Editor at Clinical Trials Week Investigators publish new report on Digestive System Diseases and Conditions- Chronic Pancreatitis. According to news reporting out of Aalborg, Denmark, by NewsRx editors, research stated, "BackgroundChronic pain is the hallmark symptom of chronic pancreatitis. Our news journalists obta
5/21/18 - Data from Peking University Third Hospital Provide New Insights into Heart Attack (Admission Macrophage Migration Inhibitory Factor Predicts...
By a News Reporter-Staff News Editor at Cardiovascular Week Research findings on Heart Disorders and Diseases- Heart Attack are discussed in a new report. According to news reporting from Beijing, People's Republic of China, by NewsRx journalists, research stated, "We previously showed in patients with ST-segment elevated myocardial infarction th
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415